Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …
L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …
A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
Hyperleukocytosis and leukostasis in acute and chronic leukemias
Leukostasis is a life-threatening complication of high concentrations of circulating leukemic
cells, most often myeloblasts. Effective care of patients with leukostasis involves early …
cells, most often myeloblasts. Effective care of patients with leukostasis involves early …
Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia—A systematic review and meta‐analysis
Background Up to 20% of patients with acute myeloid leukemia (AML) present with
hyperleukocytosis, usually defined as a white blood cell (WBC) count greater than 100× …
hyperleukocytosis, usually defined as a white blood cell (WBC) count greater than 100× …
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short-and long-term clinical outcomes: a large …
Hyperleukocytosis in acute myeloid leukemia (AML) is associated with inferior outcomes.
There is limited high quality evidence to support the benefits of leukapheresis. We …
There is limited high quality evidence to support the benefits of leukapheresis. We …
Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits
RM Shallis, M Stahl, JP Bewersdorf… - Expert Review of …, 2020 - Taylor & Francis
Introduction Hyperleukocytosis, defined as a total white blood cell count (WBC)> 50 or more
commonly> 100× 109 cells/L, is a presenting feature of acute myeloid leukemia (AML) in …
commonly> 100× 109 cells/L, is a presenting feature of acute myeloid leukemia (AML) in …
Leukapheresis and hyperleukocytosis, past and future
D Zhang, Y Zhu, Y Jin, NM Kaweme… - International Journal of …, 2021 - Taylor & Francis
Hyperleukocytosis is a hematologic crisis caused by excessive proliferation of leukemic cells
and has a relatively high early mortality due to a series of severe complications. Therefore …
and has a relatively high early mortality due to a series of severe complications. Therefore …
Leukapheresis does not improve early survival outcome of acute myeloid leukemia with leukostasis patients–A dual-center retrospective cohort study
I Rinaldi, RM Sari, VU Tedhy… - Journal of Blood …, 2021 - Taylor & Francis
Introduction Leukostasis is a medical emergency with high mortality which often occurs in
acute myeloid leukemia patients with hyperleukocytosis. One of the therapies that can be …
acute myeloid leukemia patients with hyperleukocytosis. One of the therapies that can be …
Effectiveness of leukapheresis on early survival in acute myeloid leukemia: An observational propensity score matching cohort study
H Lee, JH Han, JK Kim, J Yoo, HS Cho… - Journal of Clinical …, 2023 - Wiley Online Library
Background The association between leukapheresis (LK) as a treatment option for
hyperleukocytosis (HL) in patients with acute myeloid leukemia (AML) remains controversial …
hyperleukocytosis (HL) in patients with acute myeloid leukemia (AML) remains controversial …
Oncologic emergencies: traditional and contemporary
J Spring, L Munshi - Critical Care Clinics, 2021 - criticalcare.theclinics.com
It is becoming increasingly important for intensivists to rapidly identify and treat cancer-
related complications. Currently, up to 20% of intensive care unit (ICU) admissions will have …
related complications. Currently, up to 20% of intensive care unit (ICU) admissions will have …